| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.5M | +148.9% |
| R&D Expense | $112.1M | +36.3% |
| SG&A Expense | $38.5M | +1.2% |
| Operating Income | -$116.1M | -9.1% |
| Pre-tax Income | -$101.9M | -2.5% |
| Income Tax | $193K | +175.7% |
| Net Income | -$102.1M | -2.7% |
| EPS (Basic) | -$1.38 | +15.9% |
| EPS (Diluted) | -$1.38 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.2M | -12.3% |
| Accounts Receivable | $148K | -26.7% |
| Current Assets | $338.8M | +30.2% |
| Total Assets | $432.2M | +15.6% |
| Current Liabilities | $28.3M | +0.6% |
| Total Liabilities | $63.8M | -12.5% |
| Stockholders' Equity | $368.4M | +22.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.3M | -2.6% |
| Capital Expenditures | $11.6M | +79.9% |
| Investing Cash Flow | -$68.2M | +26.9% |
| Financing Cash Flow | $154.3M | +7133.8% |
| Free Cash Flow | -$104.9M | -7.7% |
| +15.9% |